Last checked at 9 Jul 2019 07:00
Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")
Directorate Change
Benchmark, the aquaculture health, nutrition and genetics business, announces that Mark Plampin will step down from his current role of Chief Financial Officer. Mark will continue in his role until a successor is appointed to ensure an orderly transition process.
After nine years in the role of Chief Financial Officer, during which time Mark has been an integral part of the team which led the Group through its Admission to AIM and the acquisitive and organic growth that followed, he has notified the Board of his decision to step down to pursue other opportunities.
The Company has commenced an external search for a successor and a further announcement will be made in due course.
Benchmark's Chairman, Peter George, commented:
"On behalf of the Board, I would like to take this opportunity to thank Mark for his considerable contribution during his time with the Group and wish him every success in the future. We have begun the search for his successor and look forward to updating on progress and ensuring a smooth handover of duties in due course."
Mark Plampin, Chief Financial Officer, commented:
"It has been a privilege to have served as Chief Financial Officer at Benchmark for almost a decade. I am proud of the significant milestones achieved during my time at Benchmark. We now have a focused pipeline of products and the infrastructure in place to support the Group's sustainable growth. I have enjoyed being part of a strong team at Benchmark and I look forward to working with my successor to ensure a smooth handover."
- Ends -
For further information, please contact:
Benchmark Holdings plc Tel: 020 3915 1236
Malcolm Pye, CEO
Ivonne Cantu, Investor Relations Director
Numis (Broker and NOMAD) Tel: 020 7260 1000
James Black / Freddie Barnfield / Freddie Naylor-Leyland
MHP Tel: 020 3128 8742
Katie Hunt / Reg Hoare /Alistair de Kare-Silver benchmark@mphc.com
Notes to Editors:
About Benchmark
Benchmark's mission is to drive sustainability in food production. We are a leading provider of aquaculture solutions in genetics, health and specialist nutrition. Our focus is on developing innovative products that help fish and shrimp producers improve their sustainability and profitability by improving yield, quality, health and welfare. Our main products are salmon eggs with superior genetic traits, specialist nutrition products for shrimp and fish, and health treatments including a sea lice treatment for salmon. We serve all the major aquaculture markets around the world and have leading market positions. Benchmark operates in 27 countries, employs 1,066 people and reported revenues of £151.5m in FY 2018.
For further information on Benchmark please visit www.benchmarkplc.com